The global market for Implantable Neuromodulation Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Implantable Neuromodulation Device players cover Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical and Synapse Biomedical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Implantable Neuromodulation Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Implantable Neuromodulation Device market, with both quantitative and qualitative data, to help readers understand how the Implantable Neuromodulation Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Implantable Neuromodulation Device market and forecasts the market size by Type (Spinal Cord Stimulation, Deep Brain Stimulation and Gastric Stimulation), by Application (Parkinson's Disease, Epilepsy, Pain and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Spinal Cord Stimulation
Deep Brain Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segmentation by application
Parkinson's Disease
Epilepsy
Pain
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Chapter Introduction
Chapter 1: Scope of Implantable Neuromodulation Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Implantable Neuromodulation Device market size (sales and revenue) and CAGR, Implantable Neuromodulation Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Implantable Neuromodulation Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Implantable Neuromodulation Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Implantable Neuromodulation Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics and Autonomic Technologies, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Implantable Neuromodulation Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Implantable Neuromodulation Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Implantable Neuromodulation Device by Country/Region, 2017, 2022 & 2028
2.2 Implantable Neuromodulation Device Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Gastric Stimulation
2.2.4 Transcranial Magnetic Stimulation
2.2.5 Transcutaneous Electrical Stimulation
2.2.6 Other
2.3 Implantable Neuromodulation Device Sales by Type
2.3.1 Global Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
2.3.2 Global Implantable Neuromodulation Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Implantable Neuromodulation Device Sale Price by Type (2017-2022)
2.4 Implantable Neuromodulation Device Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Implantable Neuromodulation Device Sales by Application
2.5.1 Global Implantable Neuromodulation Device Sale Market Share by Application (2017-2022)
2.5.2 Global Implantable Neuromodulation Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Implantable Neuromodulation Device Sale Price by Application (2017-2022)
3 Global Implantable Neuromodulation Device by Company
3.1 Global Implantable Neuromodulation Device Breakdown Data by Company
3.1.1 Global Implantable Neuromodulation Device Annual Sales by Company (2020-2022)
3.1.2 Global Implantable Neuromodulation Device Sales Market Share by Company (2020-2022)
3.2 Global Implantable Neuromodulation Device Annual Revenue by Company (2020-2022)
3.2.1 Global Implantable Neuromodulation Device Revenue by Company (2020-2022)
3.2.2 Global Implantable Neuromodulation Device Revenue Market Share by Company (2020-2022)
3.3 Global Implantable Neuromodulation Device Sale Price by Company
3.4 Key Manufacturers Implantable Neuromodulation Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Neuromodulation Device Product Location Distribution
3.4.2 Players Implantable Neuromodulation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Implantable Neuromodulation Device by Geographic Region
4.1 World Historic Implantable Neuromodulation Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Implantable Neuromodulation Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Implantable Neuromodulation Device Annual Revenue by Geographic Region
4.2 World Historic Implantable Neuromodulation Device Market Size by Country/Region (2017-2022)
4.2.1 Global Implantable Neuromodulation Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Implantable Neuromodulation Device Annual Revenue by Country/Region
4.3 Americas Implantable Neuromodulation Device Sales Growth
4.4 APAC Implantable Neuromodulation Device Sales Growth
4.5 Europe Implantable Neuromodulation Device Sales Growth
4.6 Middle East & Africa Implantable Neuromodulation Device Sales Growth
5 Americas
5.1 Americas Implantable Neuromodulation Device Sales by Country
5.1.1 Americas Implantable Neuromodulation Device Sales by Country (2017-2022)
5.1.2 Americas Implantable Neuromodulation Device Revenue by Country (2017-2022)
5.2 Americas Implantable Neuromodulation Device Sales by Type
5.3 Americas Implantable Neuromodulation Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Neuromodulation Device Sales by Region
6.1.1 APAC Implantable Neuromodulation Device Sales by Region (2017-2022)
6.1.2 APAC Implantable Neuromodulation Device Revenue by Region (2017-2022)
6.2 APAC Implantable Neuromodulation Device Sales by Type
6.3 APAC Implantable Neuromodulation Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Implantable Neuromodulation Device by Country
7.1.1 Europe Implantable Neuromodulation Device Sales by Country (2017-2022)
7.1.2 Europe Implantable Neuromodulation Device Revenue by Country (2017-2022)
7.2 Europe Implantable Neuromodulation Device Sales by Type
7.3 Europe Implantable Neuromodulation Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Implantable Neuromodulation Device by Country
8.1.1 Middle East & Africa Implantable Neuromodulation Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Implantable Neuromodulation Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Implantable Neuromodulation Device Sales by Type
8.3 Middle East & Africa Implantable Neuromodulation Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Neuromodulation Device
10.3 Manufacturing Process Analysis of Implantable Neuromodulation Device
10.4 Industry Chain Structure of Implantable Neuromodulation Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Neuromodulation Device Distributors
11.3 Implantable Neuromodulation Device Customer
12 World Forecast Review for Implantable Neuromodulation Device by Geographic Region
12.1 Global Implantable Neuromodulation Device Market Size Forecast by Region
12.1.1 Global Implantable Neuromodulation Device Forecast by Region (2023-2028)
12.1.2 Global Implantable Neuromodulation Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Implantable Neuromodulation Device Forecast by Type
12.7 Global Implantable Neuromodulation Device Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Implantable Neuromodulation Device Product Offered
13.1.3 Medtronic Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Implantable Neuromodulation Device Product Offered
13.2.3 Abbott Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Implantable Neuromodulation Device Product Offered
13.3.3 Boston Scientific Corporation Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 St. Jude Medical
13.4.1 St. Jude Medical Company Information
13.4.2 St. Jude Medical Implantable Neuromodulation Device Product Offered
13.4.3 St. Jude Medical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 St. Jude Medical Main Business Overview
13.4.5 St. Jude Medical Latest Developments
13.5 Synapse Biomedical
13.5.1 Synapse Biomedical Company Information
13.5.2 Synapse Biomedical Implantable Neuromodulation Device Product Offered
13.5.3 Synapse Biomedical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Synapse Biomedical Main Business Overview
13.5.5 Synapse Biomedical Latest Developments
13.6 Nevro Corporation
13.6.1 Nevro Corporation Company Information
13.6.2 Nevro Corporation Implantable Neuromodulation Device Product Offered
13.6.3 Nevro Corporation Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nevro Corporation Main Business Overview
13.6.5 Nevro Corporation Latest Developments
13.7 Neuropace
13.7.1 Neuropace Company Information
13.7.2 Neuropace Implantable Neuromodulation Device Product Offered
13.7.3 Neuropace Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Neuropace Main Business Overview
13.7.5 Neuropace Latest Developments
13.8 Cyberonics
13.8.1 Cyberonics Company Information
13.8.2 Cyberonics Implantable Neuromodulation Device Product Offered
13.8.3 Cyberonics Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Cyberonics Main Business Overview
13.8.5 Cyberonics Latest Developments
13.9 Autonomic Technologies
13.9.1 Autonomic Technologies Company Information
13.9.2 Autonomic Technologies Implantable Neuromodulation Device Product Offered
13.9.3 Autonomic Technologies Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Autonomic Technologies Main Business Overview
13.9.5 Autonomic Technologies Latest Developments
13.10 Avery Biomedical
13.10.1 Avery Biomedical Company Information
13.10.2 Avery Biomedical Implantable Neuromodulation Device Product Offered
13.10.3 Avery Biomedical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Avery Biomedical Main Business Overview
13.10.5 Avery Biomedical Latest Developments
13.11 Greatbatch Medical
13.11.1 Greatbatch Medical Company Information
13.11.2 Greatbatch Medical Implantable Neuromodulation Device Product Offered
13.11.3 Greatbatch Medical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Greatbatch Medical Main Business Overview
13.11.5 Greatbatch Medical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Implantable Neuromodulation Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Implantable Neuromodulation Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Spinal Cord Stimulation
Table 4. Major Players of Deep Brain Stimulation
Table 5. Major Players of Gastric Stimulation
Table 6. Major Players of Transcranial Magnetic Stimulation
Table 7. Major Players of Transcutaneous Electrical Stimulation
Table 8. Major Players of Other
Table 9. Global Implantable Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 10. Global Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
Table 11. Global Implantable Neuromodulation Device Revenue by Type (2017-2022) & ($ million)
Table 12. Global Implantable Neuromodulation Device Revenue Market Share by Type (2017-2022)
Table 13. Global Implantable Neuromodulation Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Implantable Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 15. Global Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Table 16. Global Implantable Neuromodulation Device Revenue by Application (2017-2022)
Table 17. Global Implantable Neuromodulation Device Revenue Market Share by Application (2017-2022)
Table 18. Global Implantable Neuromodulation Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Implantable Neuromodulation Device Sales by Company (2020-2022) & (K Units)
Table 20. Global Implantable Neuromodulation Device Sales Market Share by Company (2020-2022)
Table 21. Global Implantable Neuromodulation Device Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Implantable Neuromodulation Device Revenue Market Share by Company (2020-2022)
Table 23. Global Implantable Neuromodulation Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Implantable Neuromodulation Device Producing Area Distribution and Sales Area
Table 25. Players Implantable Neuromodulation Device Products Offered
Table 26. Implantable Neuromodulation Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Implantable Neuromodulation Device Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Implantable Neuromodulation Device Sales Market Share Geographic Region (2017-2022)
Table 31. Global Implantable Neuromodulation Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Implantable Neuromodulation Device Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Implantable Neuromodulation Device Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Implantable Neuromodulation Device Sales Market Share by Country/Region (2017-2022)
Table 35. Global Implantable Neuromodulation Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Implantable Neuromodulation Device Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Implantable Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 38. Americas Implantable Neuromodulation Device Sales Market Share by Country (2017-2022)
Table 39. Americas Implantable Neuromodulation Device Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Implantable Neuromodulation Device Revenue Market Share by Country (2017-2022)
Table 41. Americas Implantable Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 42. Americas Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
Table 43. Americas Implantable Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 44. Americas Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Table 45. APAC Implantable Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 46. APAC Implantable Neuromodulation Device Sales Market Share by Region (2017-2022)
Table 47. APAC Implantable Neuromodulation Device Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Implantable Neuromodulation Device Revenue Market Share by Region (2017-2022)
Table 49. APAC Implantable Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 50. APAC Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
Table 51. APAC Implantable Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 52. APAC Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Table 53. Europe Implantable Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 54. Europe Implantable Neuromodulation Device Sales Market Share by Country (2017-2022)
Table 55. Europe Implantable Neuromodulation Device Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Implantable Neuromodulation Device Revenue Market Share by Country (2017-2022)
Table 57. Europe Implantable Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 58. Europe Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
Table 59. Europe Implantable Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 60. Europe Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Implantable Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Implantable Neuromodulation Device Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Implantable Neuromodulation Device Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Implantable Neuromodulation Device Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Implantable Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Implantable Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Implantable Neuromodulation Device
Table 70. Key Market Challenges & Risks of Implantable Neuromodulation Device
Table 71. Key Industry Trends of Implantable Neuromodulation Device
Table 72. Implantable Neuromodulation Device Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Implantable Neuromodulation Device Distributors List
Table 75. Implantable Neuromodulation Device Customer List
Table 76. Global Implantable Neuromodulation Device Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Implantable Neuromodulation Device Sales Market Forecast by Region
Table 78. Global Implantable Neuromodulation Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Implantable Neuromodulation Device Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Implantable Neuromodulation Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Implantable Neuromodulation Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Implantable Neuromodulation Device Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Implantable Neuromodulation Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Implantable Neuromodulation Device Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Implantable Neuromodulation Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Implantable Neuromodulation Device Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Implantable Neuromodulation Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Implantable Neuromodulation Device Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Implantable Neuromodulation Device Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Implantable Neuromodulation Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Implantable Neuromodulation Device Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Implantable Neuromodulation Device Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Implantable Neuromodulation Device Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Implantable Neuromodulation Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Implantable Neuromodulation Device Revenue Market Share Forecast by Application (2023-2028)
Table 96. Medtronic Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 97. Medtronic Implantable Neuromodulation Device Product Offered
Table 98. Medtronic Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. Medtronic Main Business
Table 100. Medtronic Latest Developments
Table 101. Abbott Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbott Implantable Neuromodulation Device Product Offered
Table 103. Abbott Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Abbott Main Business
Table 105. Abbott Latest Developments
Table 106. Boston Scientific Corporation Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Boston Scientific Corporation Implantable Neuromodulation Device Product Offered
Table 108. Boston Scientific Corporation Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Boston Scientific Corporation Main Business
Table 110. Boston Scientific Corporation Latest Developments
Table 111. St. Jude Medical Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 112. St. Jude Medical Implantable Neuromodulation Device Product Offered
Table 113. St. Jude Medical Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. St. Jude Medical Main Business
Table 115. St. Jude Medical Latest Developments
Table 116. Synapse Biomedical Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Synapse Biomedical Implantable Neuromodulation Device Product Offered
Table 118. Synapse Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Synapse Biomedical Main Business
Table 120. Synapse Biomedical Latest Developments
Table 121. Nevro Corporation Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 122. Nevro Corporation Implantable Neuromodulation Device Product Offered
Table 123. Nevro Corporation Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Nevro Corporation Main Business
Table 125. Nevro Corporation Latest Developments
Table 126. Neuropace Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Neuropace Implantable Neuromodulation Device Product Offered
Table 128. Neuropace Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Neuropace Main Business
Table 130. Neuropace Latest Developments
Table 131. Cyberonics Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 132. Cyberonics Implantable Neuromodulation Device Product Offered
Table 133. Cyberonics Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. Cyberonics Main Business
Table 135. Cyberonics Latest Developments
Table 136. Autonomic Technologies Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 137. Autonomic Technologies Implantable Neuromodulation Device Product Offered
Table 138. Autonomic Technologies Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. Autonomic Technologies Main Business
Table 140. Autonomic Technologies Latest Developments
Table 141. Avery Biomedical Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Avery Biomedical Implantable Neuromodulation Device Product Offered
Table 143. Avery Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 144. Avery Biomedical Main Business
Table 145. Avery Biomedical Latest Developments
Table 146. Greatbatch Medical Basic Information, Implantable Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 147. Greatbatch Medical Implantable Neuromodulation Device Product Offered
Table 148. Greatbatch Medical Implantable Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 149. Greatbatch Medical Main Business
Table 150. Greatbatch Medical Latest Developments
List of Figures
Figure 1. Picture of Implantable Neuromodulation Device
Figure 2. Implantable Neuromodulation Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Neuromodulation Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Implantable Neuromodulation Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Implantable Neuromodulation Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Spinal Cord Stimulation
Figure 10. Product Picture of Deep Brain Stimulation
Figure 11. Product Picture of Gastric Stimulation
Figure 12. Product Picture of Transcranial Magnetic Stimulation
Figure 13. Product Picture of Transcutaneous Electrical Stimulation
Figure 14. Product Picture of Other
Figure 15. Global Implantable Neuromodulation Device Sales Market Share by Type in 2021
Figure 16. Global Implantable Neuromodulation Device Revenue Market Share by Type (2017-2022)
Figure 17. Implantable Neuromodulation Device Consumed in Parkinson's Disease
Figure 18. Global Implantable Neuromodulation Device Market: Parkinson's Disease (2017-2022) & (K Units)
Figure 19. Implantable Neuromodulation Device Consumed in Epilepsy
Figure 20. Global Implantable Neuromodulation Device Market: Epilepsy (2017-2022) & (K Units)
Figure 21. Implantable Neuromodulation Device Consumed in Pain
Figure 22. Global Implantable Neuromodulation Device Market: Pain (2017-2022) & (K Units)
Figure 23. Implantable Neuromodulation Device Consumed in Other
Figure 24. Global Implantable Neuromodulation Device Market: Other (2017-2022) & (K Units)
Figure 25. Global Implantable Neuromodulation Device Sales Market Share by Application (2017-2022)
Figure 26. Global Implantable Neuromodulation Device Revenue Market Share by Application in 2021
Figure 27. Implantable Neuromodulation Device Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Implantable Neuromodulation Device Revenue Market Share by Company in 2021
Figure 29. Global Implantable Neuromodulation Device Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Implantable Neuromodulation Device Revenue Market Share by Geographic Region in 2021
Figure 31. Global Implantable Neuromodulation Device Sales Market Share by Region (2017-2022)
Figure 32. Global Implantable Neuromodulation Device Revenue Market Share by Country/Region in 2021
Figure 33. Americas Implantable Neuromodulation Device Sales 2017-2022 (K Units)
Figure 34. Americas Implantable Neuromodulation Device Revenue 2017-2022 ($ Millions)
Figure 35. APAC Implantable Neuromodulation Device Sales 2017-2022 (K Units)
Figure 36. APAC Implantable Neuromodulation Device Revenue 2017-2022 ($ Millions)
Figure 37. Europe Implantable Neuromodulation Device Sales 2017-2022 (K Units)
Figure 38. Europe Implantable Neuromodulation Device Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Implantable Neuromodulation Device Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Implantable Neuromodulation Device Revenue 2017-2022 ($ Millions)
Figure 41. Americas Implantable Neuromodulation Device Sales Market Share by Country in 2021
Figure 42. Americas Implantable Neuromodulation Device Revenue Market Share by Country in 2021
Figure 43. United States Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Implantable Neuromodulation Device Sales Market Share by Region in 2021
Figure 48. APAC Implantable Neuromodulation Device Revenue Market Share by Regions in 2021
Figure 49. China Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Implantable Neuromodulation Device Sales Market Share by Country in 2021
Figure 56. Europe Implantable Neuromodulation Device Revenue Market Share by Country in 2021
Figure 57. Germany Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Implantable Neuromodulation Device Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Implantable Neuromodulation Device Revenue Market Share by Country in 2021
Figure 64. Egypt Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Implantable Neuromodulation Device Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Implantable Neuromodulation Device in 2021
Figure 70. Manufacturing Process Analysis of Implantable Neuromodulation Device
Figure 71. Industry Chain Structure of Implantable Neuromodulation Device
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)